Summary
In this a16z podcast conversation, billionaire entrepreneur Mark Cuban discusses how AI could reshape entrepreneurship, including the idea that solo founders may be able to build enormous businesses with the help of AI tools. He is joined by a16z’s Julie for a wide-ranging discussion grounded largely in his work in healthcare.
A large portion of the episode covers Cost Plus Drugs, which launched in January 2022 with 111 generic medications and has grown to roughly 4,000 products. Cuban explains the Team Cuban Card, a discount program tied to about 17,000 pharmacies, and the company’s push into manufacturing, including plans for compact production pods and the FDA application costs that stand in the way of onshoring generic drug production. He also describes how the mere presence of transparent pricing has pushed incumbents to change.
On technology, Cuban argues that better tools alone will not fix healthcare, pointing to regulatory capture and scale capture among large vertically integrated insurers whose earnings calls emphasize shareholder returns rather than lower costs for employers and patients. The conversation also turns to how AI will change the nature of jobs in the industry and where founders should look for under-served opportunities. Viewers interested in AI-driven entrepreneurship, healthcare economics, and the future of work will find plenty to take away.
📺 Source: a16z · Published October 28, 2026
🏷️ Format: Interview
